期刊文献+

新辅助放化疗在预防食管癌微转移中的作用 被引量:5

Effect of neo-adjuvant radiochemotherapy in the prevention of micrometastasis in esophageal squamous cell carcinoma
暂未订购
导出
摘要 目的:通过术前应用5-FU和顺铂,同时行食管区的体外照射40Gy,术后行淋巴结微转移检测,了解新辅助放化疗在降低微转移中的作用。方法:120例食管癌患者随机分为单纯手术组、新辅助化疗+手术组,每组60例。新辅助化疗组术前给予5-FU和顺铂,3周为一周期,同时行食管区的体外照射40Gy,完成两周期后在全麻下行左开胸食管部分切除食管胃颈部吻合术,并清扫区域淋巴结。HE染色"阴性淋巴结"组,免疫组化染色。结果:新辅助放化疗组CK(AE1/AE3)单克隆抗体阳性反应淋巴结数明显少于单纯手术组,有显著性差异。结论:新辅助放化疗方案,可以有效控制微转移。 Objective:To evaluate the value of neo - adjuvant radiochemotherapy in the prevention of micrometas- tasis in esophageal squamous cell carcinoma. Methods:All 120 cases of esophageal squamous cell carcinoma were randomly divided in two groups:surgery group and neo - adjuvant radiochemotherapy plus surgery group. The second group:cisplatin,fluorouracil and 40Gy radiotherapy was used before operation. A total of 326 lymph nodes were exam- ined immunohistochemically. Results:AE1/AE3 -positive lymph node metastases were found lesser in neo - adjuvant radiochemotherapy group than in surgery group. Conclusion : Neo - adjuvant radiochemotherapy is effective in the pre- vention of micrometastasis in esophageal squamous ceil carcinoma.
出处 《现代肿瘤医学》 CAS 2013年第1期94-96,共3页 Journal of Modern Oncology
关键词 新辅助放化疗 食管鳞癌 微转移 neo - adjuvant radiochemotherapy esophageal squamous cell carcinoma micrometastasis
  • 相关文献

参考文献20

  • 1Baba M, Aikou T,Yoshinaka H,et al. Long - term results of subto-tal esophagectomy with three - field lymphadenectomy for carcino-ma of the thoracic esophagus[ J]. Ann Surg, 1994,219(3) :310-316.
  • 2王洲,殷洪年.肺癌隐匿性淋巴结转移的诊断及其意义[J].中国肺癌杂志,2001,4(5):396-398. 被引量:12
  • 3Jiao X,Krasna MJ. Clinical significance of micrometastasis in lungand esophageal cancer: a new paradigm in thoracic oncology [ J].Ann Thorac Surg,2002,74( 1) :278 -284.
  • 4Prenzel KL, Konig A, Schneider PM, et al. Reduced incidence ofnodal micrometastasis after major response to neoadjuvant chemora-diation in locaily advanced esophageal cancer [ J ]. Ann Surg On-col,2007 ,14(2) :954-959.
  • 5Imdahl A. Neoadjuvant therapy in oesophageal cancer surgery [J] .Zentralbl Chir,2006,131 (2) : 105 - 109.
  • 6Schwer AL, Ballonoff A, Me Cammon R, et al. Survival effect ofneoadjuvant radiotherapy before esophagectomy for patients with e-sophageal cancer: a surveillance, epidemiology, and end - resultsstudy[ J]. Int J Radiat Oncol Biol Phys,2008,6:4.
  • 7Berger AC,Farma J,Scott WJ,et al. Complete response to neoadju-vant chemoradiotherapy in esophageal carcinoma is associated withsignificantly improved survival [ J]. J Clin Oncol,2005 ,23 ( 19 )4330-4337.
  • 8Tepper J,Krasna MJ,Niedzwiecki D,et al. Phase HI trial of trimo-daiity therapy with cisplatin, fluorouracil, radiotherapy, and surgerycompared with surgery alone for esophageal cancer : CALGB 9781[J]. J Clin Oncol, 2008,26( 7) :1086 -1092.
  • 9Gebski V,Burmeister B,Sraithers BM,et al. Survival benefits fromneoadjuvant chemoradiotherapy or chemotherapy in oesophagealcarcinoma:a meta - analysis[ J]. Lancet Oncol,2007,8(3) :226 -234.
  • 10Ku GY, Ilson DH. Multimodality therapy for the curative treatmentof cancer of the esophagus and gastroesophageal junction [ J ]. Ex-pert Rev Anticancer Ther,2008,8( 12) :1953 - 1964.

二级参考文献1

共引文献11

同被引文献36

引证文献5

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部